# Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian Patients

> **NCT04385407** · PHASE2 · COMPLETED · sponsor: **Beni-Suef University** · enrollment: 203 (actual)

## Conditions studied

- Chronic Hepatitis C Virus Infection

## Interventions

- **DRUG:** Sofosbuvir + Simeprevir + Ribavirin

## Key facts

- **NCT ID:** NCT04385407
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2020-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04385407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04385407, "Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04385407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*